0001628280-26-026458
SEC filingRevenue grew 14.0% to $22.2B with gross profit up 5.3% to $2.5B, but operating income edged down 2.8% to $448M amid higher BCA spending, yielding a narrower net loss of $4M and improved EPS of -$0.11.
Operating income of $448 million represented a modest 2.8% decline from $461 million, yielding a 2.0% operating margin. The slight pressure arose from elevated expenses, particularly higher spending at BCA, which offset gross profit gains. This dynamic highlights ongoing investments in commercial programs amid a backdrop of backlog conversion, where unobligated backlog fell $448 million due to BDS decreases partially offset by BGS increases. Investors should note that backlog excludes options, customer financing, and orders with unilateral termination rights or unresolved contingencies like board approvals or financing, underscoring execution risks.
The net loss narrowed sharply 89.2% to $4 million from $37 million, with diluted EPS improving 31.2% to -$0.11 from -$0.16. This progress reflects better operational leverage and reduced non-operating impacts, though pension and postretirement costs remain influenced by market-driven factors like plan asset returns and actuarial losses. Management views core earnings measures as offering deeper operational insights by excluding FAS/CAS service cost adjustments and non-service benefit components.
Cash from operating activities rebounded to a $179 million outflow from $1.6 billion, aided by favorable advances and payables timing, enabling working capital management amid growth. However, capital expenditures doubled to $1.3 billion, resulting in $1.5 billion free cash flow burn. This reflects sustained investment in production capacity and program development, consistent with backlog expansion. BDS continues to see opportunities across Asia, Europe, and the Middle East amid diverse threats, supporting long-term positioning despite near-term cash pressures.